JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5301
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.36B
| $60K | ﹤0.01% |
+765
| New | +$60.9K |
2022 Q4
0 quarters
|
|
5302
VanEck Emerging Markets High Yield Bond ETF
HYEM
$508M
| $60K | ﹤0.01% |
3,280
| – | – |
2020 Q1
11 quarters
|
|
5303
State Street SPDR NYSE Technology ETF
XNTK
$2.13B
| $60K | ﹤0.01% |
619
+579
| +1,448% | +$57.4K |
2020 Q3
9 quarters
|
|
|
CSML
5304
DELISTED
IndexIQ ETF Trust IQ U.S. Small Cap ETF
CSML
| $60K | ﹤0.01% |
+1,874
| New | +$60K |
2022 Q4
0 quarters
|
|
5305
CleanSpark
CLSK
$3.21B
| $59K | ﹤0.01% |
28,822
+1,201
| +4% | +$3.11K |
2021 Q1
7 quarters
|
|
5306
Corebridge Financial
CRBG
$15.5B
| $59K | ﹤0.01% |
2,964
-1,467,257
| -100% | -$31M |
2022 Q3
1 quarter
|
|
5307
iShares Global REIT ETF
REET
$4.6B
| $59K | ﹤0.01% |
2,578
-463
| -15% | -$10.3K |
2020 Q2
10 quarters
|
|
|
SBT
5308
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $59K | ﹤0.01% |
9,725
+463
| +5% | +$2.9K |
2018 Q1
19 quarters
|
|
|
ICPT
5309
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $59K | ﹤0.01% |
4,800
-94,100
| -95% | -$1.33M |
2022 Q2
2 quarters
|
|
|
FXLV
5310
DELISTED
F45 Training Holdings Inc.
FXLV
| $59K | ﹤0.01% |
21,006
-12,491
| -37% | -$37.9K |
2021 Q3
5 quarters
|
|
|
GRNA
5311
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $59K | ﹤0.01% |
50,950
-15,300
| -23% | -$24.9K |
2022 Q1
3 quarters
|
|
|
PFSW
5312
DELISTED
PFSweb, Inc.
PFSW
| $59K | ﹤0.01% |
9,595
+404
| +4% | +$3.77K |
2021 Q4
4 quarters
|
|
5313
WisdomTree International Multifactor Fund
DWMF
$33.2M
| $58K | ﹤0.01% |
+2,475
| New | +$57.7K |
2022 Q4
0 quarters
|
|
5314
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.33B
| $58K | ﹤0.01% |
610
+518
| +563% | +$49.6K |
2022 Q2
2 quarters
|
|
|
MCR
5315
DELISTED
MFS Charter Income Trust
MCR
| $58K | ﹤0.01% |
+9,370
| New | +$59.7K |
2022 Q4
0 quarters
|
|
|
MUE
5316
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
| $58K | ﹤0.01% |
5,875
+5,284
| +894% | +$52.5K |
2022 Q3
1 quarter
|
|
5317
Summit Therapeutics
SMMT
$13.8B
| $58K | ﹤0.01% |
13,582
+1,190
| +10% | +$2.17K |
2020 Q3
9 quarters
|
|
5318
InfraCap MLP ETF
AMZA
$464M
| $57K | ﹤0.01% |
1,799
+1,791
| +22,388% | +$56.9K |
2021 Q1
7 quarters
|
|
5319
Fresenius Medical Care
FMS
$12.1B
| $57K | ﹤0.01% |
3,432
+885
| +35% | +$13.1K |
2013 Q2
38 quarters
|
|
5320
First Trust Energy AlphaDEX Fund
FXN
$372M
| $57K | ﹤0.01% |
3,350
+3,249
| +3,217% | +$58.3K |
2020 Q2
10 quarters
|
|
5321
CALL
Strategy Inc
MSTR
$65.6B
| $57K | ﹤0.01% |
4,000
| – | – |
2022 Q2
2 quarters
|
|
|
HOLI
5322
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $57K | ﹤0.01% |
3,463
-189
| -5% | -$3.15K |
2021 Q3
5 quarters
|
|
5323
Cenntro
CENN
$9.31M
| $56K | ﹤0.01% |
211
+43
| +26% | +$19.5K |
2022 Q1
3 quarters
|
|
5324
iShares MSCI USA Equal Weighted ETF
EUSA
$1.9B
| $56K | ﹤0.01% |
+774
| New | +$56.2K |
2022 Q4
0 quarters
|
|
5325
Invesco AI and Next Gen Software ETF
IGPT
$1.47B
| $56K | ﹤0.01% |
1,872
+1,113
| +147% | +$34.4K |
2019 Q2
14 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.